Buscar
Mostrando ítems 1-10 de 143014
Participação das citocinas IL-4, IL-13 e IL-33 na resposta imunológica induzida pela infecção experimental por Strongyloides venezuelensis emcamundongos
(Universidade Federal de Minas GeraisUFMG, 2012-03-26)
Even though the importance of Th2 response in protection against nematodes is well established, the effector mechanism controlling the parasite can be different in each species. It was demonstrated in mice infected with ...
IL-1β, IL-2 and IL-4 concentration during porcine gestation
(Elsevier, 2022)
Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.
(Universidad del Zulia, 2009)
Evaluación de IL-23 e IL-17A y sus receptores IL-23R e IL-17RA en pacientes con Artritis Reumatoide que presenten Periodontitis
(Biblioteca Digital wdg.biblioUniversidad de Guadalajara, 2021-05-18)
Introducción: La artritis reumatoide (AR) y la periodontitis (P) son enfermedades inflamatorias crónicas caracterizadas por la pérdida ósea articular y radiográfica, respectivamente. IL-23 e IL-17A tienen un papel esencial ...
Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin - than on footpad-infected mice
(ACADEMIC PRESS INC ELSEVIER SCIENCESAN DIEGO, 2012)
Lesion development in tegumentary leishmaniasis is markedly influenced by the inoculation site and the type and number of injected infective forms. This and the yet unclear contribution of Th2 cytokines as susceptibility ...
IL-1β, IL-2 and IL-4 concentration during porcine gestation
(Elsevier Science Inc, 2019-04-01)
In pigs, given the type of epitheliochorial and non-invasive placenta, the trophoblast is in intimate contact with maternal tissues. The dialogue established between the conceptus and the endometrium involves, among others, ...
Análise de citocinas, quimiocinas e fatores de crescimento em endoftalmite infecciosas aguda pós-facectomia
(Universidade Federal de PernambucoUFPEBrasilPrograma de Pos Graduacao em Cirurgia, 2016)
Interleukin (IL)-35 is raising our expectations
(Sociedad Médica de Santiago, 2010)